Pharma IQ | 04/20/2010
Pharma IQ speaks with Earl Sullivan, Chief Executive Officer, Landela Pharmaceutical, about working with an overseas CMO to gain FDA inspection and approved status.
To continue reading this story Click Here
RECOMMENDED
Digital Transformation in Pharma: Navigating CMO Partnerships and Supply Chain Resilience
2025-01-22
Sustainability and Inclusivity in Pharma Manufacturing: Insights from AstraZeneca’s People Hub
2024-12-11
Upcoming Events
Pharmaceutical Launch Excellence Summit
2 - 3 December, 2025
UK
Register Now |
View Agenda |
Learn More